LRIG1 and central nervous system cancer: Lrig1 has been shown to be more highly expressed in gliomas than other human cancers (Ji et al., 2022) and genome-wide association studies have identified a risk allele (rs11706832) associated with glioma susceptibility (Melin et al., 2017).